Transvenous Intramyocardial Cellular Delivery Increases Retention in Comparison to Intracoronary Delivery in a Porcine Model of Acute Myocardial Infarction

Background: Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine whether transvenous intramyocardial (TVIM) approach was advantageous for cellular retention in AMI. Methods: Domestic pigs (n = 4...

Full description

Saved in:
Bibliographic Details
Published inJournal of interventional cardiology Vol. 21; no. 5; pp. 424 - 431
Main Authors GEORGE, JON C., GOLDBERG, JONATHAN, JOSEPH, MATTHEW, ABDULHAMEED, NASREEN, CRIST, JOSHUA, DAS, HIRANMOY, POMPILI, VINCENT J.
Format Journal Article
LanguageEnglish
Published Malden, USA Blackwell Publishing Inc 01.10.2008
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine whether transvenous intramyocardial (TVIM) approach was advantageous for cellular retention in AMI. Methods: Domestic pigs (n = 4) underwent catheterization with coronary angiography and ventriculography prior to infarction and pre‐ and post‐cells. Pigs underwent 90‐minute balloon occlusion of the left anterior descending artery (LAD). After one week they were prepared for IC (n = 2) or TVIM (n = 2) delivery of bone marrow mononuclear cells (MNC) labeled with GFP. IC infusion used an over‐the‐wire catheter to engage the LAD and balloon inflation to prevent retrograde flow. Venography via the coronary sinus was used for TVIM delivery. The anterior interventricular vein was engaged with a guidewire allowing use of the TransAccess™ catheter that is outfitted with an ultrasound tip for visualization. Animals were sacrificed one hour after delivery and tissue was analyzed. Results: Procedures were performed without complication and monitoring was uneventful. 1 × 108 MNC were isolated from each bone marrow (BM) preparation and 1 × 107 MNC delivered. Ventriculography at one week revealed wall motion abnormalities consistent with an anterior AMI. TVIM and IC delivery revealed mean 452 cells per section and 235 cells per section on average, respectively, in the infarct zone (P = 0.01). Conclusion: We have demonstrated that TVIM approach for cell delivery is feasible and safe. Moreover, this approach may provide an advantage over IC infusion in retention of the cellular product; however, larger studies will be necessary.
AbstractList Background: Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine whether transvenous intramyocardial (TVIM) approach was advantageous for cellular retention in AMI. Methods: Domestic pigs (n = 4) underwent catheterization with coronary angiography and ventriculography prior to infarction and pre‐ and post‐cells. Pigs underwent 90‐minute balloon occlusion of the left anterior descending artery (LAD). After one week they were prepared for IC (n = 2) or TVIM (n = 2) delivery of bone marrow mononuclear cells (MNC) labeled with GFP. IC infusion used an over‐the‐wire catheter to engage the LAD and balloon inflation to prevent retrograde flow. Venography via the coronary sinus was used for TVIM delivery. The anterior interventricular vein was engaged with a guidewire allowing use of the TransAccess™ catheter that is outfitted with an ultrasound tip for visualization. Animals were sacrificed one hour after delivery and tissue was analyzed. Results: Procedures were performed without complication and monitoring was uneventful. 1 × 10 8 MNC were isolated from each bone marrow (BM) preparation and 1 × 10 7 MNC delivered. Ventriculography at one week revealed wall motion abnormalities consistent with an anterior AMI. TVIM and IC delivery revealed mean 452 cells per section and 235 cells per section on average, respectively, in the infarct zone ( P  = 0.01 ). Conclusion: We have demonstrated that TVIM approach for cell delivery is feasible and safe. Moreover, this approach may provide an advantage over IC infusion in retention of the cellular product; however, larger studies will be necessary.
Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine whether transvenous intramyocardial (TVIM) approach was advantageous for cellular retention in AMI. Domestic pigs (n = 4) underwent catheterization with coronary angiography and ventriculography prior to infarction and pre- and post-cells. Pigs underwent 90-minute balloon occlusion of the left anterior descending artery (LAD). After one week they were prepared for IC (n = 2) or TVIM (n = 2) delivery of bone marrow mononuclear cells (MNC) labeled with GFP. IC infusion used an over-the-wire catheter to engage the LAD and balloon inflation to prevent retrograde flow. Venography via the coronary sinus was used for TVIM delivery. The anterior interventricular vein was engaged with a guidewire allowing use of the TransAccess catheter that is outfitted with an ultrasound tip for visualization. Animals were sacrificed one hour after delivery and tissue was analyzed. Procedures were performed without complication and monitoring was uneventful. 1 x 10(8) MNC were isolated from each bone marrow (BM) preparation and 1 x 10(7) MNC delivered. Ventriculography at one week revealed wall motion abnormalities consistent with an anterior AMI. TVIM and IC delivery revealed mean 452 cells per section and 235 cells per section on average, respectively, in the infarct zone (P = 0.01). We have demonstrated that TVIM approach for cell delivery is feasible and safe. Moreover, this approach may provide an advantage over IC infusion in retention of the cellular product; however, larger studies will be necessary.
BACKGROUNDClinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine whether transvenous intramyocardial (TVIM) approach was advantageous for cellular retention in AMI. METHODSDomestic pigs (n = 4) underwent catheterization with coronary angiography and ventriculography prior to infarction and pre- and post-cells. Pigs underwent 90-minute balloon occlusion of the left anterior descending artery (LAD). After one week they were prepared for IC (n = 2) or TVIM (n = 2) delivery of bone marrow mononuclear cells (MNC) labeled with GFP. IC infusion used an over-the-wire catheter to engage the LAD and balloon inflation to prevent retrograde flow. Venography via the coronary sinus was used for TVIM delivery. The anterior interventricular vein was engaged with a guidewire allowing use of the TransAccess catheter that is outfitted with an ultrasound tip for visualization. Animals were sacrificed one hour after delivery and tissue was analyzed. RESULTSProcedures were performed without complication and monitoring was uneventful. 1 x 10(8) MNC were isolated from each bone marrow (BM) preparation and 1 x 10(7) MNC delivered. Ventriculography at one week revealed wall motion abnormalities consistent with an anterior AMI. TVIM and IC delivery revealed mean 452 cells per section and 235 cells per section on average, respectively, in the infarct zone (P = 0.01). CONCLUSIONWe have demonstrated that TVIM approach for cell delivery is feasible and safe. Moreover, this approach may provide an advantage over IC infusion in retention of the cellular product; however, larger studies will be necessary.
Background: Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine whether transvenous intramyocardial (TVIM) approach was advantageous for cellular retention in AMI. Methods: Domestic pigs (n = 4) underwent catheterization with coronary angiography and ventriculography prior to infarction and pre‐ and post‐cells. Pigs underwent 90‐minute balloon occlusion of the left anterior descending artery (LAD). After one week they were prepared for IC (n = 2) or TVIM (n = 2) delivery of bone marrow mononuclear cells (MNC) labeled with GFP. IC infusion used an over‐the‐wire catheter to engage the LAD and balloon inflation to prevent retrograde flow. Venography via the coronary sinus was used for TVIM delivery. The anterior interventricular vein was engaged with a guidewire allowing use of the TransAccess™ catheter that is outfitted with an ultrasound tip for visualization. Animals were sacrificed one hour after delivery and tissue was analyzed. Results: Procedures were performed without complication and monitoring was uneventful. 1 × 108 MNC were isolated from each bone marrow (BM) preparation and 1 × 107 MNC delivered. Ventriculography at one week revealed wall motion abnormalities consistent with an anterior AMI. TVIM and IC delivery revealed mean 452 cells per section and 235 cells per section on average, respectively, in the infarct zone (P = 0.01). Conclusion: We have demonstrated that TVIM approach for cell delivery is feasible and safe. Moreover, this approach may provide an advantage over IC infusion in retention of the cellular product; however, larger studies will be necessary.
Author GEORGE, JON C.
GOLDBERG, JONATHAN
JOSEPH, MATTHEW
CRIST, JOSHUA
POMPILI, VINCENT J.
DAS, HIRANMOY
ABDULHAMEED, NASREEN
Author_xml – sequence: 1
  givenname: JON C.
  surname: GEORGE
  fullname: GEORGE, JON C.
  organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio
– sequence: 2
  givenname: JONATHAN
  surname: GOLDBERG
  fullname: GOLDBERG, JONATHAN
  organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio
– sequence: 3
  givenname: MATTHEW
  surname: JOSEPH
  fullname: JOSEPH, MATTHEW
  organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio
– sequence: 4
  givenname: NASREEN
  surname: ABDULHAMEED
  fullname: ABDULHAMEED, NASREEN
  organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio
– sequence: 5
  givenname: JOSHUA
  surname: CRIST
  fullname: CRIST, JOSHUA
  organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio
– sequence: 6
  givenname: HIRANMOY
  surname: DAS
  fullname: DAS, HIRANMOY
  organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio
– sequence: 7
  givenname: VINCENT J.
  surname: POMPILI
  fullname: POMPILI, VINCENT J.
  organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19012733$$D View this record in MEDLINE/PubMed
BookMark eNqNkc2O0zAUhS00iOkMvALyil2KHceJvQBpKMxQmB80KmJpOc4NuCR2sdPSPgsvi0OrDuzwxrbu-c617zlDJ847QAhTMqVpvVxOKS9IJqhg05wQMSWESTLdPkKTY-EETYiQZVawvDpFZzEuCckJ5_kTdEoloXnF2AT9WgTt4gacX0c8d0PQ_c4bHRqrOzyDrlt3OuC30NkNhF1SmAA6QsT3MIAbrHfYOjzz_UoHG9Nt8Hsb44N3OiFHNuk0_uSDsQ7wjW-gw77FF2Y9pOtD07lrdTCj81P0uNVdhGeH_Rx9vny3mL3Pru-u5rOL68zwqiSZJoUGxuqmkpTltMoFKySXJeNGgyhlbeqipbysQACXNW9IAXnNeCsNM5zW7By93vuu1nUPjYHx_Z1aBdunDyivrfq34uw39dVvVFHkoizzZPDiYBD8jzXEQfU2mjQ87SDNVZWykkIWZRKKvdAEH2OA9tiEEjUmq5ZqDFCNAaoxWfUnWbVN6PO_H_kAHqJMgld7wU_bwe6_jdWHu_ksnRKf7XkbB9geeR2-q7JiFVdfbq9U9fHm9v7yDVUL9hspr8ec
CitedBy_id crossref_primary_10_1161_CIRCRESAHA_113_300219
crossref_primary_10_1007_s12265_012_9443_y
crossref_primary_10_1016_j_atherosclerosis_2014_01_027
crossref_primary_10_1186_scrt29
crossref_primary_10_1007_s10554_010_9658_4
crossref_primary_10_1007_s12265_012_9378_3
crossref_primary_10_1007_s00270_020_02625_z
crossref_primary_10_1016_j_ahj_2021_06_013
crossref_primary_10_3389_fcvm_2019_00104
crossref_primary_10_1002_micr_20779
crossref_primary_10_1186_1479_5876_11_56
crossref_primary_10_1536_ihj_16_179
crossref_primary_10_1016_j_biomaterials_2016_03_020
crossref_primary_10_1371_journal_pone_0076908
crossref_primary_10_1016_j_ijcard_2010_02_008
crossref_primary_10_1016_j_trsl_2009_06_009
crossref_primary_10_1136_pgmj_2009_192385rep
crossref_primary_10_1186_1479_5876_9_183
crossref_primary_10_1186_s13578_023_01099_z
crossref_primary_10_1161_CIRCINTERVENTIONS_123_012997
crossref_primary_10_1016_j_addr_2017_10_007
Cites_doi 10.1073/pnas.181177898
10.1002/ccd.20450
10.1097/00029330-200609020-00001
10.1016/j.ijcard.2006.03.028
10.1016/j.cardiores.2004.12.013
10.1093/eurheartj/ehi818
10.1161/01.CIR.0000138191.11580.e3
10.1093/eurheartj/ehi159
10.1016/j.ejcts.2005.01.065
10.1002/ccd.10417
10.1016/j.jtcvs.2007.05.004
10.1002/1522-726X(200011)51:3<358::AID-CCD27>3.0.CO;2-F
10.1002/ccd.20841
10.1016/S0735-1097(03)00397-8
10.3727/000000006783981611
10.1634/stemcells.2005-0212
10.1038/ncpcardio0447
10.1161/hc3501.093817
10.1016/S0735-1097(01)01200-1
ContentType Journal Article
Copyright 2008, the Authors Journal compilation ©2008, Wiley Periodicals, Inc.
Copyright_xml – notice: 2008, the Authors Journal compilation ©2008, Wiley Periodicals, Inc.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1111/j.1540-8183.2008.00390.x
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1540-8183
EndPage 431
ExternalDocumentID 10_1111_j_1540_8183_2008_00390_x
19012733
JOIC390
ark_67375_WNG_7KMNRFB1_T
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAMS NIH HHS
  grantid: K01 AR054114-01A2
– fundername: NIAMS NIH HHS
  grantid: K01 AR054114
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29K
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAJEY
AAONW
AAWTL
AAZKR
ABCQN
ABDBF
ABEML
ABJNI
ABOCM
ABPVW
ABUWG
ACBWZ
ACCFJ
ACGFS
ACMXC
ACPRK
ACSCC
ACXQS
ADBBV
ADEOM
ADIZJ
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFEBI
AFKRA
AFPWT
AFZJQ
AHEFC
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMBMR
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BCNDV
BDRZF
BENPR
BHBCM
BMXJE
BPHCQ
BPMNR
BROTX
BRXPI
BSCLL
BVXVI
BY8
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
D-I
DC6
DCZOG
DPXWK
DR2
DU5
EAD
EAP
EAS
EBD
EBS
EJD
EMB
EMK
EMOBN
ENC
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FYUFA
FZ0
G-S
G.N
GODZA
GROUPED_DOAJ
H.X
HF~
HMCUK
HVGLF
HYE
HZI
HZ~
IAO
IHE
IHR
INH
ITC
IX1
J0M
K48
LC2
LC3
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
PGMZT
PIMPY
PQQKQ
Q.N
Q11
QB0
Q~Q
R.K
RHX
RIWAO
RJQFR
ROL
RPM
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
UKHRP
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c5760-a04ae33bd79132172834959635cae869bcb4f1567e8e59b5d04e2b35f9c3c51b3
IEDL.DBID DR2
ISSN 0896-4327
IngestDate Tue Sep 17 21:25:02 EDT 2024
Fri Oct 25 11:08:19 EDT 2024
Thu Sep 26 18:49:15 EDT 2024
Sat Sep 28 07:53:47 EDT 2024
Sat Aug 24 00:48:23 EDT 2024
Wed Oct 30 09:53:17 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5760-a04ae33bd79132172834959635cae869bcb4f1567e8e59b5d04e2b35f9c3c51b3
Notes istex:DE87E2C9333BB3165795B9DA55C322DE56C43405
ark:/67375/WNG-7KMNRFB1-T
ArticleID:JOIC390
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current address: Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio
OpenAccessLink https://europepmc.org/articles/pmc4428662?pdf=render
PMID 19012733
PQID 69798946
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4428662
proquest_miscellaneous_69798946
crossref_primary_10_1111_j_1540_8183_2008_00390_x
pubmed_primary_19012733
wiley_primary_10_1111_j_1540_8183_2008_00390_x_JOIC390
istex_primary_ark_67375_WNG_7KMNRFB1_T
PublicationCentury 2000
PublicationDate October 2008
PublicationDateYYYYMMDD 2008-10-01
PublicationDate_xml – month: 10
  year: 2008
  text: October 2008
PublicationDecade 2000
PublicationPlace Malden, USA
PublicationPlace_xml – name: Malden, USA
– name: United States
PublicationTitle Journal of interventional cardiology
PublicationTitleAlternate J Interv Cardiol
PublicationYear 2008
Publisher Blackwell Publishing Inc
Publisher_xml – name: Blackwell Publishing Inc
References Freyman T, Polin G, Osman H, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006;27:1114-1122.
Ott HC, Kroess R, Bonaros N, et al. Intramyocardial microdepot injection increases the efficacy of skeletal myoblast transplantation. Eur J Cardiothorac Surg 2005;27:1017-1021.
Hou D, Maclaughlin F, Thiesse M, et al. Widespread regional myocardial transfection by plasmid encoding Del-1 following retrograde coronary venous delivery. Catheter Cardiovasc Interv 2003;58:207-211.
Siminiak T, Fiszer D, Jerzykowska O, et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: The POZNAN trial. Eur Heart J 2005;26:1188-1195.
Thompson CA, Nasseri BA, Makower J, et al. Percutaneous transvenous cellular cardiomyoplasty: A novel nonsurgical approach for myocardial cell transplantation. J Am Col Cardiol 2003;41:1964-1971.
Musialek P, Tracz W, Skotnicki AB, et al. Transcoronary stem cell delivery using physiological endothelium-targeting perfusion technique: The rationale and a pilot study involving a comparison with conventional over-the-wire balloon coronary occlusions in patients after recent myocardial infarction. Kardiol Pol 2006;64:489-498.
Hu CH, Wu GF, Wang XQ, et al. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction. Chin Med J 2006;119:1499-1506.
Hou D, Youssef EAS, Brinton TJ, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials. Circulation 2005;112(suppl I):I150-I156.
Perin EC, Lopez J. Methods of stem cell delivery in cardiac diseases. Nat Clin Pract Cardiovasc Med 2006;3(suppl I):S110-S113.
Leor J, Guetta E, Feinberg MS, et al. Human umbilical cord blood-derived CD133 +cells enhance function and repair of the infarcted myocardium. Stem Cells 2006;24:772-780.
Bhakta S, Greco NJ, Finney MR, et al. The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia. J Invasive Cardiol 2006;18:212-218.
Baklanov DV, Moodie KM, McCarthy FE, et al. Comparison of transendocardial and retrograde coronary venous intramyocardial catheter delivery systems in healthy and infarcted pigs. Catheter Cardiovasc Interv 2006;68:416-423.
Ma N, Stamm C, Kaminski A, et al. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/SCID mice. Cardiovasc Res 2005;66:45-54.
Youssef EAS, Zhang P, Rogers PI, et al. Enhancing myocardial plasmid expression by retrograde coronary venous delivery. Catheter Cardiovasc Interv 2005;65:528-534.
Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001;37:1726-1732.
Hou M, Yang KM, Zhang H, et al. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int J Cardiol 2007;115:220-228.
Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001;104:1046-1052.
Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function, and survival. Proc Natl Acad Sci USA 2001;98:10344-10349.
Kim BO, Tian H, Prasongsukarn K, et al. Cell transplantation improves ventricular function after a myocardial infarction: A preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 2005;112(suppl 9):I96-104.
Suzuki K, Murtuza B, Fukushima S, et al. Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: Distribution, dynamics, and influence on cardiac function. Circulation 2004;110(suppl II):II-225-230.
Makela J, Ylitalo K, Lehtonen S, et al. Bone marrow-derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction site. J Thorac Cardiovasc Surg 2007;134:565-573.
Herity NA, Lo ST, Oei F, et al. Selective regional myocardial infiltration by the percutaneous coronary venous route: A novel technique for local drug delivery. Catheter Cardiovasc Interv 2000;51:358-363.
Henning RJ, Burgos JD, Ondrovic L, et al. Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size. Cell Transplant 2006;15:647-658.
Marzilli M. Recurrent and resistant angina: Is the metabolic approach an appropriate answer? Coron Artery Dis 2004;15(suppl I):S23-S27.
2007; 115
2004; 110
2007; 134
2006; 64
2006; 119
2006; 24
2006; 68
2005; 112
2006; 27
2004; 15
2006; 15
2000; 51
2003; 58
2006; 18
2005; 65
2006; 3
2001; 37
2005; 26
2005; 27
2003; 41
2001; 104
2005; 66
2001; 98
16510464 - Eur Heart J. 2006 May;27(9):1114-22
15364867 - Circulation. 2004 Sep 14;110(11 Suppl 1):II225-30
16752333 - Kardiol Pol. 2006 May;64(5):489-98; discussion 499
12798567 - J Am Coll Cardiol. 2003 Jun 4;41(11):1964-71
15769447 - Cardiovasc Res. 2005 Apr 1;66(1):45-54
16889848 - Int J Cardiol. 2007 Feb 7;115(2):220-8
11345391 - J Am Coll Cardiol. 2001 May;37(6):1726-32
16195418 - Stem Cells. 2006 Mar;24(3):772-80
11066126 - Catheter Cardiovasc Interv. 2000 Nov;51(3):358-63
11504914 - Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10344-9
15896611 - Eur J Cardiothorac Surg. 2005 Jun;27(6):1017-21
15179125 - Coron Artery Dis. 2004 May;15 Suppl 1:S23-7
11524400 - Circulation. 2001 Aug 28;104(9):1046-52
16159808 - Circulation. 2005 Aug 30;112(9 Suppl):I150-6
12552546 - Catheter Cardiovasc Interv. 2003 Feb;58(2):207-11
16159872 - Circulation. 2005 Aug 30;112(9 Suppl):I96-104
16670448 - J Invasive Cardiol. 2006 May;18(5):212-8
17176616 - Cell Transplant. 2006;15(7):647-58
16501616 - Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S110-3
16003788 - Catheter Cardiovasc Interv. 2005 Aug;65(4):528-34
16892441 - Catheter Cardiovasc Interv. 2006 Sep;68(3):416-23
17723800 - J Thorac Cardiovasc Surg. 2007 Sep;134(3):565-73
16996002 - Chin Med J (Engl). 2006 Sep 20;119(18):1499-506
15764613 - Eur Heart J. 2005 Jun;26(12):1188-95
Kim BO (e_1_2_6_22_2) 2005; 112
Bhakta S (e_1_2_6_6_2) 2006; 18
e_1_2_6_18_2
e_1_2_6_19_2
Musialek P (e_1_2_6_11_2) 2006; 64
e_1_2_6_13_2
e_1_2_6_10_2
e_1_2_6_16_2
Hou D (e_1_2_6_12_2) 2005; 112
e_1_2_6_17_2
e_1_2_6_14_2
e_1_2_6_15_2
e_1_2_6_20_2
Marzilli M (e_1_2_6_3_2) 2004; 15
e_1_2_6_8_2
e_1_2_6_7_2
e_1_2_6_9_2
e_1_2_6_4_2
e_1_2_6_5_2
e_1_2_6_24_2
e_1_2_6_23_2
e_1_2_6_2_2
e_1_2_6_21_2
e_1_2_6_26_2
e_1_2_6_25_2
References_xml – volume: 134
  start-page: 565
  year: 2007
  end-page: 573
  article-title: Bone marrow‐derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction site
  publication-title: J Thorac Cardiovasc Surg
– volume: 15
  start-page: S23
  issue: suppl I
  year: 2004
  end-page: S27
  article-title: Recurrent and resistant angina: Is the metabolic approach an appropriate answer?
  publication-title: Coron Artery Dis
– volume: 58
  start-page: 207
  year: 2003
  end-page: 211
  article-title: Widespread regional myocardial transfection by plasmid encoding Del‐1 following retrograde coronary venous delivery
  publication-title: Catheter Cardiovasc Interv
– volume: 27
  start-page: 1114
  year: 2006
  end-page: 1122
  article-title: A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction
  publication-title: Eur Heart J
– volume: 112
  start-page: I150
  issue: suppl I
  year: 2005
  end-page: I156
  article-title: Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials
  publication-title: Circulation
– volume: 104
  start-page: 1046
  year: 2001
  end-page: 1052
  article-title: Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines
  publication-title: Circulation
– volume: 112
  start-page: I96
  issue: suppl 9
  year: 2005
  end-page: 104
  article-title: Cell transplantation improves ventricular function after a myocardial infarction: A preclinical study of human unrestricted somatic stem cells in a porcine model
  publication-title: Circulation
– volume: 66
  start-page: 45
  year: 2005
  end-page: 54
  article-title: Human cord blood cells induce angiogenesis following myocardial infarction in NOD/SCID mice
  publication-title: Cardiovasc Res
– volume: 26
  start-page: 1188
  year: 2005
  end-page: 1195
  article-title: Percutaneous trans‐coronary‐venous transplantation of autologous skeletal myoblasts in the treatment of post‐infarction myocardial contractility impairment: The POZNAN trial
  publication-title: Eur Heart J
– volume: 41
  start-page: 1964
  year: 2003
  end-page: 1971
  article-title: Percutaneous transvenous cellular cardiomyoplasty: A novel nonsurgical approach for myocardial cell transplantation
  publication-title: J Am Col Cardiol
– volume: 119
  start-page: 1499
  year: 2006
  end-page: 1506
  article-title: Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction
  publication-title: Chin Med J
– volume: 98
  start-page: 10344
  year: 2001
  end-page: 10349
  article-title: Mobilized bone marrow cells repair the infarcted heart, improving function, and survival
  publication-title: Proc Natl Acad Sci USA
– volume: 115
  start-page: 220
  year: 2007
  end-page: 228
  article-title: Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats
  publication-title: Int J Cardiol
– volume: 24
  start-page: 772
  year: 2006
  end-page: 780
  article-title: Human umbilical cord blood‐derived CD133 +cells enhance function and repair of the infarcted myocardium
  publication-title: Stem Cells
– volume: 3
  start-page: S110
  issue: suppl I
  year: 2006
  end-page: S113
  article-title: Methods of stem cell delivery in cardiac diseases
  publication-title: Nat Clin Pract Cardiovasc Med
– volume: 18
  start-page: 212
  year: 2006
  end-page: 218
  article-title: The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia
  publication-title: J Invasive Cardiol
– volume: 110
  start-page: II‐225
  issue: suppl II
  year: 2004
  end-page: 230
  article-title: Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: Distribution, dynamics, and influence on cardiac function
  publication-title: Circulation
– volume: 64
  start-page: 489
  year: 2006
  end-page: 498
  article-title: Transcoronary stem cell delivery using physiological endothelium‐targeting perfusion technique: The rationale and a pilot study involving a comparison with conventional over‐the‐wire balloon coronary occlusions in patients after recent myocardial infarction
  publication-title: Kardiol Pol
– volume: 68
  start-page: 416
  year: 2006
  end-page: 423
  article-title: Comparison of transendocardial and retrograde coronary venous intramyocardial catheter delivery systems in healthy and infarcted pigs
  publication-title: Catheter Cardiovasc Interv
– volume: 37
  start-page: 1726
  year: 2001
  end-page: 1732
  article-title: Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia
  publication-title: J Am Coll Cardiol
– volume: 15
  start-page: 647
  year: 2006
  end-page: 658
  article-title: Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size
  publication-title: Cell Transplant
– volume: 65
  start-page: 528
  year: 2005
  end-page: 534
  article-title: Enhancing myocardial plasmid expression by retrograde coronary venous delivery
  publication-title: Catheter Cardiovasc Interv
– volume: 51
  start-page: 358
  year: 2000
  end-page: 363
  article-title: Selective regional myocardial infiltration by the percutaneous coronary venous route: A novel technique for local drug delivery
  publication-title: Catheter Cardiovasc Interv
– volume: 27
  start-page: 1017
  year: 2005
  end-page: 1021
  article-title: Intramyocardial microdepot injection increases the efficacy of skeletal myoblast transplantation
  publication-title: Eur J Cardiothorac Surg
– ident: e_1_2_6_4_2
  doi: 10.1073/pnas.181177898
– ident: e_1_2_6_2_2
– ident: e_1_2_6_26_2
  doi: 10.1002/ccd.20450
– ident: e_1_2_6_21_2
  doi: 10.1097/00029330-200609020-00001
– volume: 15
  start-page: S23
  year: 2004
  ident: e_1_2_6_3_2
  article-title: Recurrent and resistant angina: Is the metabolic approach an appropriate answer?
  publication-title: Coron Artery Dis
  contributor:
    fullname: Marzilli M
– ident: e_1_2_6_18_2
  doi: 10.1016/j.ijcard.2006.03.028
– ident: e_1_2_6_23_2
  doi: 10.1016/j.cardiores.2004.12.013
– ident: e_1_2_6_7_2
  doi: 10.1093/eurheartj/ehi818
– ident: e_1_2_6_9_2
  doi: 10.1161/01.CIR.0000138191.11580.e3
– ident: e_1_2_6_13_2
  doi: 10.1093/eurheartj/ehi159
– volume: 112
  start-page: I96
  issue: 9
  year: 2005
  ident: e_1_2_6_22_2
  article-title: Cell transplantation improves ventricular function after a myocardial infarction: A preclinical study of human unrestricted somatic stem cells in a porcine model
  publication-title: Circulation
  contributor:
    fullname: Kim BO
– ident: e_1_2_6_8_2
  doi: 10.1016/j.ejcts.2005.01.065
– ident: e_1_2_6_25_2
  doi: 10.1002/ccd.10417
– ident: e_1_2_6_19_2
  doi: 10.1016/j.jtcvs.2007.05.004
– ident: e_1_2_6_24_2
  doi: 10.1002/1522-726X(200011)51:3<358::AID-CCD27>3.0.CO;2-F
– ident: e_1_2_6_14_2
  doi: 10.1002/ccd.20841
– ident: e_1_2_6_10_2
  doi: 10.1016/S0735-1097(03)00397-8
– ident: e_1_2_6_20_2
  doi: 10.3727/000000006783981611
– ident: e_1_2_6_5_2
  doi: 10.1634/stemcells.2005-0212
– ident: e_1_2_6_15_2
  doi: 10.1038/ncpcardio0447
– ident: e_1_2_6_16_2
  doi: 10.1161/hc3501.093817
– ident: e_1_2_6_17_2
  doi: 10.1016/S0735-1097(01)01200-1
– volume: 18
  start-page: 212
  year: 2006
  ident: e_1_2_6_6_2
  article-title: The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia
  publication-title: J Invasive Cardiol
  contributor:
    fullname: Bhakta S
– volume: 64
  start-page: 489
  year: 2006
  ident: e_1_2_6_11_2
  article-title: Transcoronary stem cell delivery using physiological endothelium‐targeting perfusion technique: The rationale and a pilot study involving a comparison with conventional over‐the‐wire balloon coronary occlusions in patients after recent myocardial infarction
  publication-title: Kardiol Pol
  contributor:
    fullname: Musialek P
– volume: 112
  start-page: I150
  year: 2005
  ident: e_1_2_6_12_2
  article-title: Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials
  publication-title: Circulation
  contributor:
    fullname: Hou D
SSID ssj0020552
Score 2.0007691
Snippet Background: Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed...
Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine...
Background: Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed...
BACKGROUNDClinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to...
SourceID pubmedcentral
proquest
crossref
pubmed
wiley
istex
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 424
SubjectTerms Analysis of Variance
Angioplasty, Balloon, Coronary - methods
Animals
Bone Marrow Transplantation - methods
Contrast Media
Coronary Angiography - methods
Disease Models, Animal
Fluoroscopy
Myocardial Infarction - therapy
Myocardial Reperfusion - methods
Regeneration
Stem Cell Transplantation - methods
Sus scrofa
Title Transvenous Intramyocardial Cellular Delivery Increases Retention in Comparison to Intracoronary Delivery in a Porcine Model of Acute Myocardial Infarction
URI https://api.istex.fr/ark:/67375/WNG-7KMNRFB1-T/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1540-8183.2008.00390.x
https://www.ncbi.nlm.nih.gov/pubmed/19012733
https://search.proquest.com/docview/69798946
https://pubmed.ncbi.nlm.nih.gov/PMC4428662
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQIiEuvB_h6QPilqqxkzg-Ll3KdlELqnbF3izbcbSrlhS1Kdrlr_BnmXEe3cAeEOKWKH5l8k1mJp58Q8gb7iIrZZKHqdYsjE0EOqd1HrJYcO0SyYynY5jO0sOT-Og0OW3yn_BfmJofovvghprh39eo4Nps-kqOm_pgcHibEgnx-wD9yYgLzO46mHdMUmyY-OI7w0ymYcyZ6Cf1XDtQz1LdRKFfXOeG_plNedXL9WZqfJcs2huss1MWg21lBvbHb9yP_0cC98idxpul-zX87pMbrnxAbk2b_fqH5Kc3hd89Dyyd4MK_XoLxRFAu6cgtl5gESw9gHaBRl9ACfdiN29A5-vKIGXpe0lFXK5FWq3oYi8QLsPJdX2in6efVGiemWOFtSVcF3bfbCk53k07KAlQbR35ETsbvj0eHYVMOIrQQFA1DPYy149zkQkIIjXW1OER38AJJrHZZKo01cQHhqHAZgMwk-TB2zPCkkJbbJDL8MdkrV6V7SqgxENVmholI2jgrhMm5YdrkDryfwgoekKh99OpbzfqhrkRLIHWFUm9qeKLU1UVA3nqMdB30eoFZcyJRX2YflPg4nc3H7yJ1HJDXLYgU6DJu0OjSwXNQqRTIh58G5EkNqd3kElMEOCxM9MDWNUCW8P6V8vzMs4XHEGCmKQtI6rH01_ejjj5NRnD07F87Pie3WUseHL0ge9V6616CB1eZV143fwG-AztR
link.rule.ids 230,315,783,787,888,1378,27938,27939,46308,46732
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hVgIu5V3Mq3tA3BzZXtvrPZaUkLRNQFEqelvtrteiquug1EEtf4U_y4xfqaEHhLjZ8r48ns8z4x1_Q8hbZn0jRJS6sVKBG2ofMKdU6gYhZ8pGItAVHcN0Fo9PwsPT6LQpB4T_wtT8EN0HN0RG9b5GgOMH6T7KcVcfLA5rcyIhgB-AQ7kN6GdYzuBg3nFJBV5Uld_xEhG7IQt4P63n1pF6tmobxX51myP6Zz7lTT-3MlSjByRvb7HOTzkfrEs9MD9-Y3_8TzJ4SHYah5bu1xr4iNyxxWNyd9ps2T8hPytr-L2igqUTXPnFNdhP1MucDm2eYx4sPYCFAKiuoQW6sZf2ks7RnUe1oWcFHXblEmm5rIcxyL0AS9_0hXaKfl6ucGKKRd5yuszovlmXcLqZdFJkgG4c-Sk5GX1YDMduUxHCNRAXea7yQmUZ0ykXEEVjaS0GAR68QyKjbBILbXSYQUTKbQJ6pqPUC22gWZQJw0zka_aMbBXLwj4nVGsIbBMdcF-YMMm4TpkOlE4tOECZ4cwhfvvs5bea-EPeCJhA6hKl3pTxRKnLK4e8q5Sk66BW55g4xyP5ZfZR8qPpbD5678uFQ_ZaLZIAZ9yjUYWF5yBjwZESP3bIbq1Tm8kFZgkwWBjvaVvXAInC-1eKs68VYXgIMWYcBw6JK2X66_uRh58mQzh68a8d98i98WJ6LI8ns6OX5H7Qcgn7r8hWuVrb1-DQlfpNBdRfU8c_aw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb5tAEF5ViRT10veD9JE9VL1hAQu7cEztunFSu5GVqLmtdpdFjeziyMFR0r_SP9uZxeDQ5lBVvYHYF8M3zAw7fEPIO2ZDk2VJ7nOlIj_WIeicUrkfxYIpm2SRdnQM4wk_OI0Pz5Kzdf4T_gtT80O0H9xQM9z7GhX8Ii-6So6b-mBwWJMSCfF7D_zJ7ZizANO7BtOWSioKEld9J0gz7scsEt2snjtH6piqbZT69V1-6J_plLfdXGenhg_JrLnDOj1l1ltVumd-_Eb--H9E8Ig8WLuzdL_G32Nyz5ZPyM54vWH_lPx0tvDKEcHSES78-w1YT0TlnPbtfI5ZsHQA6wCVuoEW6MRe2ks6RWceQUPPS9pviyXSalEPY5B5AVa-6QvtFD1eLHFiiiXe5nRR0H2zquB0M-moLEC3ceRn5HT48aR_4K_rQfgGoqLAV0GsLGM6FxnE0FhYi0F4B2-QxCib8kwbHRcQjwqbAsp0kgexjTRLiswwk4SaPSdb5aK0LwnVGsLaVEcizEycFkLnTEdK5xbcn8II5pGwefTyoqb9kLfCJZC6RKmvi3ii1OW1R947jLQd1HKGaXMikV8nn6Q4Gk-mww-hPPHIXgMiCcqMOzSqtPAcJM8EEuJzj7yoIbWZPMMcAQYLEx2wtQ2QJrx7pTz_5ujCY4gwOY88wh2W_vp-5OGXUR-Odv-14x7ZOR4M5efR5OgVuR81RMLha7JVLVf2DXhzlX7r1PQXXps-Gg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transvenous+intramyocardial+cellular+delivery+increases+retention+in+comparison+to+intracoronary+delivery+in+a+porcine+model+of+acute+myocardial+infarction&rft.jtitle=Journal+of+interventional+cardiology&rft.au=George%2C+Jon+C&rft.au=Goldberg%2C+Jonathan&rft.au=Joseph%2C+Matthew&rft.au=Abdulhameed%2C+Nasreen&rft.date=2008-10-01&rft.eissn=1540-8183&rft.volume=21&rft.issue=5&rft.spage=424&rft.epage=431&rft_id=info:doi/10.1111%2Fj.1540-8183.2008.00390.x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0896-4327&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0896-4327&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0896-4327&client=summon